Actively Recruiting
Impact of Urodynamic and Video-urodynamic Testing on Surgical Outcomes in Women With Recurrent Urinary Incontinence
Led by University College, London · Updated on 2026-05-05
30
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the feasibility of a prospective randomized trial comparing outcomes of surgery for recurrent urinary incontinence in women using two diagnostic tests: standard urodynamic testing (UDS) and video-urodynamic testing (VUDS). The study addresses the challenge of poor correlation between urinary symptoms and underlying dysfunction, aiming to determine which test better informs treatment decisions. This pilot study involves 30 adult women with recurrent stress urinary incontinence after failed continence surgery. Participants will be randomly assigned to undergo either UDS or VUDS before receiving medical or surgical treatment tailored to their diagnosis. UDS is performed in an outpatient setting without X-rays by trained medical personnel, while VUDS requires X-ray imaging in a radiology department with specialized staff. Both tests follow standardized protocols at University College London Hospitals. Treatment is provided by the Functional, Reconstructive and Adolescent Urology team. During the study, women will be assessed using validated questionnaires to measure urinary incontinence symptoms six months after treatment. Researchers will also evaluate patient characteristics, X-ray exposure, patient experience, outcomes, and costs. This comprehensive assessment will help identify subgroups of women who may benefit more from either UDS or VUDS and clarify when these tests should be avoided. Participation involves diagnostic testing, treatment, and follow-up over at least six months.
CONDITIONS
Brief Title
Impact of CMG vs VCMG in Recurrent Stress Incontinence- A Pilot Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Competent (able to consent)
- Adult women (over 18 years old)
- With recurrent stress urinary incontinence
You will not qualify if you...
- Women who are pregnant
- Unfit for surgery
- Body mass index (BMI) over 35
- History of pelvic radiotherapy or relevant neurogenic disease that may risk neurogenic bladder
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo urodynamic or video-urodynamic testing to assess urinary incontinence.
1 visit (in-person)
Duration - 6 months
Participants are monitored for surgical outcomes following diagnostic testing.
Follow-up visits as scheduled up to 6 months
Trial Site Locations
Total: 1 location
1
University College Hospital at Westmoreland Street
London, United Kingdom, W1G 8PH
Actively Recruiting
Research Team
B
Bogdan Toia, MD (Romania)
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here